Summary
Fund+ is a financial institution; the bankruptcy model is trained on trading and manufacturing companies and does not apply here. The 2025 annual accounts show equity of €124.0m and a net result of -€1.8m. Equity is growing by ~2.8% per year across the filed fiscal years. Its solvency ranks better than 95% of 5565 sector peers (fiscal year 2025). The company has been active since 2015 and the Belgian State Gazette contains no insolvency or warning signals.
Checked score
Outside the general model
Model not applicable to financial institutions
The Checked score weighs liquidity, leverage and margins against norms for trading and manufacturing companies. A bank, insurer or financial holding has a fundamentally different balance-sheet structure, so those ratios, and hence the score, carry no meaning here. That is why we show no financial axes either.
Credit check for your own amount and term
Open the credit simulator : see how the verdict changes with amount, term and advance.
Signals
1 signal. The signal on the left, the evidence on the right.
○neutral
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 09-06-2026, 52 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
52 d early
2024
45 d early
2023
33 d early
2022
40 d early
2021
53 d early
2020
38 d early
2019
37 d early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 7 accounts on average 43 days before the deadline; the sector median for financial year 2024 is 14 days before the deadline, and 28% of the sector filed late.
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
27-09-2026 today31-12-2026 close31-07-2027 deadline
History
On 7 May 2015, Fund+ was incorporated by Désiré Collen Stichting and Life Sciences Research Partners, with a starting capital of EUR 9 million.12 The capital was increased 6 times between 2015 and 2026, most recently to EUR 106 million.345 Of the 6 current board members, Luc Debruyne has served longest, since 2023.6 Total assets went from EUR 91 million in 2018 to EUR 124 million in 2025 and headcount from 0.1 to 1 full-time equivalents.7
Go further with this company
How much credit can you give this customer, and on what term?Credit simulator What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check What changed in the latest annual accounts?What changed Is the workforce growing, and do people stay?Employer check
Is this your company? See how customers and banks see it.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2025, abbreviated schema
In the rankings
#6 company by equity in Leuven, Finance and insurance sector#9 company by total assets in Leuven, Finance and insurance sector
Equity
€124.0m▲ 2.3%
2024 · €121.3m
Net result
-€1.8m
2024 · €2.3m
Total assets
€124.1m▲ 0.9%
2024 · €123.0m
Solvency
99.9%▲ 1.3pp
2024 · 98.6%
Trend over the years
Click a name to add, emphasise or remove a line.
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20212022202320242025
Turnover€1,695
Operating result-€2.6m▼ 26.9%-€2.6m▲ 0.2%-€3.0m▼ 12.4%-€2.1m▲ 28.4%-€1.6m▲ 25.9%
Net result€21.4m▲ 4,211%-€4.3m€17.2m€2.3m▼ 86.7%-€1.8m
Equity€123.9m▲ 162%€119.6m▼ 3.5%€119.0m▼ 0.5%€121.3m▲ 1.9%€124.0m▲ 2.3%
Total assets€129.6m▲ 22.6%€119.8m▼ 7.5%€143.5m▲ 19.8%€123.0m▼ 14.3%€124.1m▲ 0.9%
Debt€5.7m▼ 90.2%€245,208▼ 95.7%€24.5m▲ 9,908%€1.7m▼ 92.9%€98,832▼ 94.3%
Working capital€41.2m€15.0m▼ 63.5%€15.0m▼ 0.4%€31.1m▲ 108%€14.5m▼ 53.3%
Solvency95.6%▲ 50.8pp99.8%▲ 4.2pp82.9%▼ 16.9pp98.6%▲ 15.7pp99.9%▲ 1.3pp
Staff (FTE)0.7▼ 12.5%1.3▲ 85.7%1.7▲ 30.8%1▼ 41.2%1=
Turnover and EBIT margin not published: the abbreviated schema does not require them.
Why a figure moved sharply
- 2024 Net result -87% on 2023. Cause not known from the registers.
- 2021 Net result +4,211%, Equity +162% on 2020. Cause not known from the registers.
Result per fiscal year
Operating resultNet result
The operating result stays negative: a loss of €1.6m in 2025 against €2.1m in 2024; the loss shrinks.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €124.1m
Fixed assets
€109.5m ▲ 21.4%
Current assets
€14.6m ▼ 55.6%
Equity and liabilities €124.1m
Equity
€124.0m ▲ 2.3%
Debt
€98,832 ▼ 94.3%
Debt's share of the balance-sheet total falls from 1.4% to 0.1%. Equity is higher and debt is lower.
Key figures and ratios
ROE
-1.4%▼
2024 · 1.9%
ROA
-1.4%▼
2024 · 1.9%
Debt ≤ 1 year
€43,818▼
2024 · €1.7m
Debt > 1 year
€0
Income taxes
-€5,766▼
2024 · -€159
Staff costs
€260,072▲
2024 · €194,231
A ratio outside any meaningful range has been withheld (balance sheet total €124.1m, equity €124.0m).
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Annual accounts
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Turnover70 | - | - | - | €1,695 | - | - |
| Non-recurring operating income76A | - | €140 | - | - | - | - |
| Goods, raw materials, services and sundry goods60/61 | - | - | - | €1.9m | €1.3m | ▼ 31.9% |
| Remuneration, social security and pensions62 | €76,116 | €114,045 | €230,161 | €194,231 | €260,072 | ▲ 33.9% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €801 | €2,415 | €6,104 | €3,963 | €3,054 | ▼ 22.9% |
| Other operating charges640/8 | €40 | €210,885 | - | €394 | €7 | ▼ 98.2% |
| Non-recurring operating charges66A | - | €1,599 | - | €3,225 | €1,820 | ▼ 43.6% |
| Gross operating margin9900 | -€2.6m | -€2.3m | -€2.7m | -€1.9m | -€1.3m | ▲ 31.8% |
| Operating profit (loss)9901 | -€2.6m | -€2.6m | -€3.0m | -€2.1m | -€1.6m | ▲ 25.9% |
| Financial income75/76B | €28.3m | €2.0m | €37.9m | €21.3m | €814,173 | ▼ 96.2% |
| Recurring financial income75 | €1.8m | €1.7m | €2.3m | €853,227 | €814,173 | ▼ 4.6% |
| Non-recurring financial income76B | €26.5m | €284,511 | €35.6m | €20.5m | - | - |
| Financial charges65/66B | €4.1m | €3.7m | €17.7m | €16.9m | €1.0m | ▼ 94.0% |
| Recurring financial charges65 | €1.1m | €3.7m | €11.6m | €834,974 | €1.0m | ▲ 20.9% |
| Non-recurring financial charges66B | €3.1m | - | €6.1m | €16.1m | - | - |
| Profit (loss) for the period before taxes9903 | €21.5m | -€4.4m | €17.2m | €2.3m | -€1.8m | ▼ 177% |
| Income taxes67/77 | €105,998 | -€137,928 | €5,924 | -€159 | -€5,766 | ▼ 3,527% |
| Profit (loss) for the period9904 | €21.4m | -€4.3m | €17.2m | €2.3m | -€1.8m | ▼ 177% |
| Profit (loss) for the period to be appropriated9905 | €21.4m | -€4.3m | €17.2m | €2.3m | -€1.8m | ▼ 177% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €129.6m | €119.8m | €143.5m | €123.0m | €124.1m | ▲ 0.9% |
| Fixed assets21/28 | €82.7m | €104.6m | €104.0m | €90.2m | €109.5m | ▲ 21.4% |
| Tangible fixed assets22/27 | €4,569 | €6,655 | €7,014 | €8,272 | €6,475 | ▼ 21.7% |
| Furniture and vehicles24 | €4,569 | €6,655 | €7,014 | €8,272 | €6,475 | ▼ 21.7% |
| Financial fixed assets28 | €82.7m | €104.6m | €104.0m | €90.2m | €109.5m | ▲ 21.4% |
| Current assets29/58 | €46.9m | €15.3m | €39.5m | €32.8m | €14.6m | ▼ 55.6% |
| Amounts receivable within one year40/41 | €2.2m | €447,489 | €35.6m | €7,428 | €136,318 | ▲ 1,735% |
| Trade receivables40 | €263 | €301,608 | - | €1,503 | - | - |
| Other amounts receivable41 | €2.2m | €145,881 | €35.6m | €5,925 | €136,318 | ▲ 2,201% |
| Current investments50/53 | €44.0m | €14.2m | €2.2m | €24.4m | €10.3m | ▼ 58.0% |
| Cash at bank and in hand54/58 | €804,148 | €678,459 | €1.6m | €8.3m | €4.2m | ▼ 49.7% |
| Deferred charges and accrued income490/1 | - | €139 | - | €74,137 | - | - |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €129.6m | €119.8m | €143.5m | €123.0m | €124.1m | ▲ 0.9% |
| Equity10/15 | €123.9m | €119.6m | €119.0m | €121.3m | €124.0m | ▲ 2.3% |
| Contributions10/11 | €102.4m | €102.4m | €102.4m | €102.4m | €106.9m | ▲ 4.4% |
| Capital10 | €101.2m | €101.2m | €101.2m | €101.2m | €105.7m | ▲ 4.4% |
| Issued capital100 | €101.2m | €101.2m | €101.2m | €101.2m | €105.7m | ▲ 4.4% |
| Outside capital11 | €1.2m | €1.2m | €1.2m | €1.2m | €1.2m | = |
| Share premium1100/10 | €1.2m | €1.2m | €1.2m | €1.2m | €1.2m | = |
| Revaluation surpluses12 | - | - | - | - | €0 | - |
| Reserves13 | €4.6m | €4.6m | €5.5m | €5.6m | €5.6m | = |
| Non-distributable reserves130/1 | €4.6m | €4.6m | €5.5m | €5.6m | €5.6m | = |
| Legal reserve130 | €4.6m | €4.6m | €5.5m | €5.6m | €5.6m | = |
| Profit (loss) carried forward14 | €16.8m | €12.6m | €11.1m | €13.3m | €11.5m | ▼ 13.3% |
| Investment grants15 | - | - | - | - | €0 | - |
| Advance to shareholders on the distribution of net assets19 | - | - | - | - | €0 | - |
| Amounts payable17/49 | €5.7m | €245,208 | €24.5m | €1.7m | €98,832 | ▼ 94.3% |
| Amounts payable after more than one year17 | - | - | - | - | €0 | - |
| Amounts payable within one year42/48 | €5.7m | €245,208 | €24.5m | €1.7m | €43,818 | ▼ 97.4% |
| Current portion of amounts payable after more than one year42 | - | - | - | - | €0 | - |
| Financial debts43 | - | - | €5.5m | - | €0 | - |
| Credit institutions430/8 | - | - | €5.5m | - | - | - |
| Trade debts44 | €59,197 | €230,342 | €1.2m | €295,265 | €20,257 | ▼ 93.1% |
| Suppliers440/4 | €59,197 | €230,342 | €1.2m | €295,265 | €20,257 | ▼ 93.1% |
| Taxes, remuneration and social security45 | €31,533 | €14,866 | €20,311 | €19,951 | €23,561 | ▲ 18.1% |
| Taxes450/3 | €29,888 | - | - | - | - | - |
| Remuneration and social security454/9 | €1,645 | €14,866 | €20,311 | €19,951 | €23,561 | ▲ 18.1% |
| Other amounts payable47/48 | €5.6m | - | €17.8m | €1.4m | - | - |
| Accrued charges and deferred income492/3 | €1,743 | - | - | €27,345 | €55,014 | ▲ 101% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €21.4m | -€4.3m | €17.2m | €2.3m | -€1.8m | ▼ 177% |
| + Depreciation and write-downs630 | €801 | €2,415 | €6,104 | €3,963 | €3,054 | ▼ 22.9% |
| Operating cash flow (approximation) | €21.4m | -€4.3m | €17.2m | €2.3m | -€1.8m | ▼ 177% |
| Investment in fixed assets (approximation) | - | -€21.9m | €538,197 | €13.8m | -€19.3m | ▼ 240% |
| Change in cash | - | -€125,689 | €967,077 | €6.6m | -€4.1m | ▼ 162% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
09-06
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema
22-01
State Gazette act
Resignation: FONTAINE François (director)Appointment: FEDERALE PARTICIPATIE- EN INVESTERINGSMAATSCHAPPIJ (director) · Permanent representative: FONTAINE François · Capital increase9 facts ▸
State Gazette act
Resignation: FONTAINE François (director)
Appointment: FEDERALE PARTICIPATIE- EN INVESTERINGSMAATSCHAPPIJ (director) · Permanent representative: FONTAINE François · Capital increase9 facts ▸
- General meeting, 19-12-2025
- Director resignation, FONTAINE François (director)
- Director appointment, FEDERALE PARTICIPATIE- EN INVESTERINGSMAATSCHAPPIJ (director)
- Permanent representative, FONTAINE François
- Capital increase, €4.499.000
- Bank account, 18-12-2025
- Capital, €105.737.717,5
- Statutes amendment
- Power of attorney, DE LEEUW Bart
2025
31-12
Financial
Liquidity times 17current ratio 332.53
Current ratio from 19.19 to 332.53; short-term debt falls from €1.7m to €43,818.
16-06
NBB filing
Annual accounts filed
fiscal year 2024 · abbreviated schema
2024
31-12
Financial
Liquidity times 12current ratio 19.19
Current ratio from 1.61 to 19.19; short-term debt falls from €24.5m to €1.7m.
26-08
State Gazette act
Resignation: Pienter-Jan BV (director)Appointment: Chris Buyse (director)3 facts ▸
State Gazette act
Resignation: Pienter-Jan BV (director)
Appointment: Chris Buyse (director)3 facts ▸
- Board meeting, 25-06-2024
- Director resignation, Pienter-Jan BV (director)
- Director appointment, Chris Buyse (director)
28-06
State Gazette act
Resignations & appointmentsResignations: Multifin SA, Compass CommV and 3 others · Permanent representatives: Gérard Lamarche, Luc Debruyne and 3 others · Appointments: LGP Advisory BV (director) and Luc Debruyne (director)22 facts ▸
State Gazette act
Resignations & appointments
Resignations: Multifin SA, Compass CommV and 3 others · Permanent representatives: Gérard Lamarche, Luc Debruyne and 3 others · Appointments: LGP Advisory BV (director) and Luc Debruyne (director)22 facts ▸
- General meeting, 03-06-2024
- Director resignation, Multifin SA (director)
- Permanent representative, Gérard Lamarche
- Director resignation, Compass CommV (director)
- Permanent representative, Luc Debruyne
- Director resignation, Pienter-Jan BV (director)
- Permanent representative, Chris Buyse
- Director resignation, V.M.F. NV (director)
- Permanent representative, Urbanus Vandeurzen
- Director resignation, François Fontaine (director)
- Director appointment, LGP Advisory BV (director)
- Permanent representative, Kenneth Bonheure
- +10 further facts in this act
28-06
NBB filing
Annual accounts filed
fiscal year 2023 · abbreviated schema
2023
31-12
Financial
Back to profitnet €17.2m
Net result €17.2m after one loss-making year.
08-11
State Gazette act
Resignations: Mark Waer (director) and Debasish Roychowdhury (director)Appointment: Luc Debruyne (chair of the board) · Permanent representative: Chris Buyse · Power of attorney8 facts ▸
State Gazette act
Resignations: Mark Waer (director) and Debasish Roychowdhury (director)
Appointment: Luc Debruyne (chair of the board) · Permanent representative: Chris Buyse · Power of attorney8 facts ▸
- Board meeting, 20-06-2023
- Director resignation, Mark Waer (director)
- Director appointment, Luc Debruyne (chair of the board)
- Board meeting, 27-06-2023
- Director resignation, Debasish Roychowdhury (director)
- Power of attorney, Bart De Leeuw
- Permanent representative, Chris Buyse
- Power of attorney, Junomati BV
21-06
NBB filing
Annual accounts filed
fiscal year 2022 · abbreviated schema
12-06
State Gazette act
Reappointment: BDO Bedrijfsrevisoren BV (statutory auditor)Permanent representative: Beert Kegels3 facts ▸
State Gazette act
Reappointment: BDO Bedrijfsrevisoren BV (statutory auditor)
Permanent representative: Beert Kegels3 facts ▸
- General meeting, 07-06-2022
- Auditor reappointment, BDO Bedrijfsrevisoren BV
- Permanent representative, Beert Kegels
Show earlier events
2022
31-12
Financial
Weakest financial yearnet -€4.3m
Net result drops to -€4.3m, the lowest in the series; recovery starts the following year.
31-12
Financial
Liquidity times 8current ratio 62.31
Current ratio from 8.21 to 62.31; short-term debt falls from €5.7m to €245,208.
08-06
NBB filing
Annual accounts filed
fiscal year 2021 · abbreviated schema
2021
31-12
Financial
Highest result since 2018net €21.4m ▲4,211%
Net result €21.4m, the highest in the series.
31-12
Financial
Liquidity times 15current ratio 8.21
Current ratio from 0.56 to 8.21; short-term debt falls from €58.4m to €5.7m.
31-12
Financial
Equity above €100mEq €123.9m ▲162%
4 profitable years in a row build equity to €123.9m.
23-06
NBB filing
Annual accounts filed
fiscal year 2020 · abbreviated schema
2020
16-07
State Gazette act
Resignations: PIENTER-JAN BV, Francois FONTAINE and 5 othersAppointments: Mutifin BV (director) and COMPASS CommV (director) · Permanent representatives: Gerard LAMARCHE, Luc DEBRUYNE and 2 others · Reappointments: PIENTER-JAN BV, Francois FONTAINE and 2 others19 facts ▸
State Gazette act
Resignations: PIENTER-JAN BV, Francois FONTAINE and 5 others
Appointments: Mutifin BV (director) and COMPASS CommV (director) · Permanent representatives: Gerard LAMARCHE, Luc DEBRUYNE and 2 others · Reappointments: PIENTER-JAN BV, Francois FONTAINE and 2 others19 facts ▸
- General meeting, 01-06-2020
- Director resignation, PIENTER-JAN BV (director)
- Director resignation, Francois FONTAINE (director)
- Director resignation, Dr. IR. U. Vandeurzen Management Firm BV (director)
- Director resignation, Désiré COLLEN (director)
- Director resignation, Arnoud DE PRET ROOSE DE CALESBERG (director)
- Director resignation, Pierre DRION (director)
- Director resignation, Dr. D. ROYCHOWDHURY (director)
- Director appointment, Mutifin BV (director)
- Permanent representative, Gerard LAMARCHE
- Director appointment, COMPASS CommV (director)
- Permanent representative, Luc DEBRUYNE
- +7 further facts in this act
24-06
NBB filing
Annual accounts filed
fiscal year 2019 · abbreviated schema
22-04
State Gazette act
Resignation: Hilde Laga (bestuurster)2 facts ▸
State Gazette act
Resignation: Hilde Laga (bestuurster)
2 facts ▸
- Board meeting, 10-12-2019
- Director resignation, Hilde Laga (bestuurster)
2019
31-12
Financial
Liquidity triplescurrent ratio 126.93
Current ratio from 39.13 to 126.93; short-term debt falls from €1.5m to €425,080.
31-12
Financial
Equity above €100mEq €105.1m ▲18%
2 profitable years in a row build equity to €105.1m.
08-08
State Gazette act
Reappointment: BDO Bedrijfsrevisoren CVBA (statutory auditor)Permanent representative: Bert Kegels · Mandate compensation4 facts ▸
State Gazette act
Reappointment: BDO Bedrijfsrevisoren CVBA (statutory auditor)
Permanent representative: Bert Kegels · Mandate compensation4 facts ▸
- General meeting, 03-06-2019
- Auditor reappointment, BDO Bedrijfsrevisoren CVBA (statutory auditor)
- Permanent representative, Bert Kegels
- Mandate compensation, BDO Bedrijfsrevisoren CVBA
21-06
NBB filing
Annual accounts filed
fiscal year 2018 · abbreviated schema
2018
07-09
State Gazette act
Appointment: Mark Waer (director)Mandate compensation3 facts ▸
State Gazette act
Appointment: Mark Waer (director)
Mandate compensation3 facts ▸
- General meeting, 05-06-2018
- Director appointment, Mark Waer (director)
- Mandate compensation, Mark Waer
25-06
NBB filing
Annual accounts filed
fiscal year 2017 · abbreviated schema
10-01
State Gazette act
Capital & sharesCapital · Statutes amendment3 facts ▸
State Gazette act
Capital & shares
Capital · Statutes amendment3 facts ▸
- General meeting, 29-09-2017
- Capital, €101.238.717,5
- Statutes amendment
2017
31-10
State Gazette act
Permanent representative: Bert Kegels2 facts ▸
State Gazette act
Permanent representative: Bert Kegels
2 facts ▸
- Board meeting
- Permanent representative, Bert Kegels
12-10
State Gazette act
Capital & shares · Statutes amendmentApproval · Capital decrease · Power of attorney13 facts ▸
State Gazette act
Capital & shares · Statutes amendment
Approval · Capital decrease · Power of attorney13 facts ▸
- General meeting, 29-09-2017
- Statutes amendment
- Approval, 13-09-2017
- Capital decrease, €36.940.522,5
- Power of attorney, Fund+
- Capital increase, €15.000.000
- Capital increase, €8.268.000
- Capital increase, €41.475.000
- Capital increase, €14.007.900
- Capital increase, €14.088.340
- Statutes amendment
- Capital, €31.667.477,5
- +1 further facts in this act
02-08
State Gazette act
Appointments: Debasish Roychowdhury (director) and François Fontaine (director)2 facts ▸
State Gazette act
Appointments: Debasish Roychowdhury (director) and François Fontaine (director)
2 facts ▸
- Director appointment, Debasish Roychowdhury (director)
- Director appointment, François Fontaine (director)
01-07
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema
2016
14-10
State Gazette act
Capital & sharesCapital increase · Capital · Power of attorney7 facts ▸
State Gazette act
Capital & shares
Capital increase · Capital · Power of attorney7 facts ▸
- General meeting, 27-09-2016
- Capital increase, €12.300.000
- Capital increase, €7.715.000
- Capital, €45.340.000
- Power of attorney, Raad van Bestuur
- Power of attorney, Voorzitter
- Power of attorney, Gedelegeerd Bestuurder
21-01
State Gazette act
Appointment: LAGA Hilde Maria Joseph (independent director)Capital increase · Capital4 facts ▸
State Gazette act
Appointment: LAGA Hilde Maria Joseph (independent director)
Capital increase · Capital4 facts ▸
- General meeting, 30-12-2015
- Capital increase, €2.500.000
- Capital, €25.325.000
- Director appointment, LAGA Hilde Maria Joseph (independent director)
2015
14-08
State Gazette act
Capital & sharesCapital increase · Capital · Statutes amendment4 facts ▸
State Gazette act
Capital & shares
Capital increase · Capital · Statutes amendment4 facts ▸
- General meeting, 23-07-2015
- Capital increase, €4.325.000
- Capital, €22.825.000
- Statutes amendment
02-06
State Gazette act
Appointments: Dr. Ir. U. VANDEURZEN MANAGEMENT FIRM, DRION Pierre René Ghislain and DE PRET ROOSE DE CALESBERG Arnoud Alfred Marie Gaston GhislainPermanent representative: VANDEURZEN Urbanus (roepnaam Urbain) Agnes Lambert · Capital increase · Capital8 facts ▸
State Gazette act
Appointments: Dr. Ir. U. VANDEURZEN MANAGEMENT FIRM, DRION Pierre René Ghislain and DE PRET ROOSE DE CALESBERG Arnoud Alfred Marie Gaston Ghislain
Permanent representative: VANDEURZEN Urbanus (roepnaam Urbain) Agnes Lambert · Capital increase · Capital8 facts ▸
- General meeting, 13-05-2015
- Capital increase, €9.500.000
- Capital, €18.500.000
- Director appointment, Dr. Ir. U. VANDEURZEN MANAGEMENT FIRM (referentieaandeelhouder bestuurder)
- Permanent representative, VANDEURZEN Urbanus (roepnaam Urbain) Agnes Lambert
- Director appointment, DRION Pierre René Ghislain (independent director)
- Director appointment, DE PRET ROOSE DE CALESBERG Arnoud Alfred Marie Gaston Ghislain (independent director)
- Number of directors, 5
20-05
State Gazette act
IncorporationAppointments: COLLEN Désiré José Louis, PIENTER-JAN and BDO Bedrijfsrevisoren - BDO Réviseurs d'Entreprises · Permanent representative: BUYSE Chris Georges Frans · Founding capital11 facts ▸
State Gazette act
Incorporation
Appointments: COLLEN Désiré José Louis, PIENTER-JAN and BDO Bedrijfsrevisoren - BDO Réviseurs d'Entreprises · Permanent representative: BUYSE Chris Georges Frans · Founding capital11 facts ▸
- Incorporation, 07-05-2015
- Founding capital, €9.000.000
- Founder, Désiré Collen Stichting
- Founder, Life Sciences Research Partners
- Director appointment, COLLEN Désiré José Louis (dcs bestuurder)
- Director appointment, PIENTER-JAN (managing director)
- Permanent representative, BUYSE Chris Georges Frans
- Auditor appointment, BDO Bedrijfsrevisoren - BDO Réviseurs d'Entreprises
- Authorised capital, 200000000, 5 jaar
- Share issue, vergoeding inbreng in natura, 5000
- Director appointment, COLLEN Désiré José Louis (chair of the board)
Financial milestoneState Gazette actNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
18 of 19 acts read
About the unread acts
Of the 19 Belgian State Gazette acts we know for this company, 18 have been read. The other one has not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
8 directors, last change in 2025
Board 8
Luc Debruyne
CurrentChair of the board · since 08-11-2023 · Director · since 03-06-2024
DR. IR. U. VANDEURZEN MANAGEMENT FIRM
CurrentDirector · since 03-06-2024 · Public limited company · perm. rep.: VANDEURZEN Urbanus (roepnaam Urbain) Agnes Lambert
FONTAINE François Gabriel
CurrentDirector · since 03-06-2024
LGP Advisory
CurrentDirector · since 03-06-2024 · Private limited company · perm. rep.: Kenneth Bonheure
Chris Buyse
CurrentDirector · since 25-06-2024
SOCIETE FEDERALE DE PARTICIPATIONS ET D'INVESTISSEMENT
CurrentDirector · since 04-09-2025 · Public limited company · perm. rep.: FONTAINE François
FEDERALE PARTICIPATIE- EN INVESTERINGSMAATSCHAPPIJ
CurrentDirector · since 22-01-2026 · Legal entity · from a recent act
V.M.F. NV
CurrentDirector · Legal entity · from a recent act
2 not recently confirmed
Still in office according to the acts, but no act of the last six years confirms the mandate. It has often ended since, in an act we have not read.
COLLEN Désiré José Louis
Not recently confirmedChair of the board · since 07-05-2015 · Dcs bestuurder · since 07-05-2015
Dr. D. ROYCHOWDHURY
Not recently confirmedDirector · since 01-06-2020
Day-to-day management 1
PIENTER-JAN
Not recently confirmedManaging director · since 07-05-2015 · Legal entity · perm. rep.: BUYSE Chris Georges Frans
Permanent representatives 3
Kenneth Bonheure
CurrentPermanent representative · since 03-06-2024 · for LGP Advisory
VANDEURZEN Urbanus (roepnaam Urbain) Agnes Lambert
CurrentPermanent representative · since 03-06-2024 · for DR. IR. U. VANDEURZEN MANAGEMENT FIRM
FONTAINE François
CurrentPermanent representative · since 04-09-2025 · for SOCIETE FEDERALE DE PARTICIPATIONS ET D'INVESTISSEMENT
1 not recently confirmed
Still in office according to the acts, but no act of the last six years confirms the mandate. It has often ended since, in an act we have not read.
BUYSE Chris Georges Frans
Not recently confirmedPermanent representative · since 07-05-2015 · for PIENTER-JAN
Statutory auditor 1
BDO Bedrijfsrevisoren bv
CurrentAuditor · since 08-05-2015 · perm. rep.: Beert Kegels
"From a recent act": read from a Gazette act not yet processed into our list of directors.
Derived from published Gazette acts. The CBE keeps the official list of function holders; we do not read it, so the two can differ.
See the function holders in the CBE →
Not every act has been read: a resignation may be missing here
1 of this company's 19 Belgian State Gazette acts has not been read yet. Appointments and resignations recorded in them are missing above: a director who resigned there may therefore still show here as sitting. The acts are in the Timeline.
Location & real-estate footprint
Registered office, Leuven · 1 establishment unit since 2015
Ground area
1,571 m²
Building footprint
158 m²
Volume, LiDAR
1,482 m³
Parcel 24504D1049/00M000, Flanders · tallest building 13.3 m, ±3 floors. Linked by address, not a title deed.
1 establishment unit
Fund+
since 20152.244.735.693
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 24504D1049/00M000 | Flanders | 1,571 m² | 1 · 158 m² | 13.3 m · 3 fl. |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
1 of these parcels carry protected heritage: expect extra rules on renovation or sale.
Mandate history
20 people since 2015, 12 in office
- Board
- Day-to-day management
- Statutory auditor
- Other function
- not recently confirmed
- began earlier
| Name | Functions and periods |
|---|---|
| DR. IR. U. VANDEURZEN MANAGEMENT FIRM |
|
| Luc Debruyne |
|
| FONTAINE François Gabriel |
|
| LGP Advisory |
|
| Chris Buyse |
|
| V.M.F. NVfrom an act |
|
| SOCIETE FEDERALE DE PARTICIPATIONS ET D'INVESTISSEMENT |
|
| FEDERALE PARTICIPATIE- EN INVESTERINGSMAATSCHAPPIJfrom an act |
|
| BDO Bedrijfsrevisoren bv |
|
| COLLEN Désiré José Louis |
|
| Dr. D. ROYCHOWDHURY |
|
| PIENTER-JAN |
|
| FONTAINE François |
|
| MULTIFIN |
|
| Debasish Roychowdhury |
|
| Marc Waer |
|
| DE PRET ROOSE DE CALESBERG Arnoud Alfred Marie Gaston Ghislain |
|
| Désiré COLLEN |
|
| Pierre Drion |
|
| Prof. Hilde Laga |
|
Articles of association
Purpose
De Vennootschap heeft tot doel het functioneren als een beleggings- en investeringsvennootschap en daartoe de door haar aangetrokken middelen te beleggen, en dit voornamelijk maar…
Full purpose
De Vennootschap heeft tot doel het functioneren als een beleggings- en investeringsvennootschap en daartoe de door haar aangetrokken middelen te beleggen, en dit voornamelijk maar niet uitsluitend in ondernemingen en andere entiteiten die actief zijn in de wetenschappen die vallen onder de noemer life sciences (o.m. de biowetenschappen, de medische wetenschappen) en de wetenschappen in het algemeen, en alle daarmee gerelateerde technologieën, ontwikkelingen en toepassingen.
Structure & network
Owners and holdings
3 owners · 18 holdingsOwners 3
- 19.5%
-
13.1%
-
12.29%
Holdings 18
-
20.21%
- Equity -€3.5mResult €41,10019.93%
-
19.61%
-
19.02%
-
17.16%
-
16.7%
-
14.15%
-
12.64%
-
10.6%
-
10.3%
Show 8 more holdings
-
8.48%
-
8.33%
-
7.53%
- Equity €50.6mResult -€11.2m7.17%
-
6.33%
-
6.27%
-
3.08%
-
0.86%
According to the 2025 annual accounts of Fund+ and those of the other companies, the acts in the Belgian Gazette and the LEI register. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not fill in these statements, or need not, is missing.
Connections & network
74 connected companiesThis company
Company
Director
Shareholding
+N: links not shown yet
Click a node to look further, drag to arrange, scroll to zoom.
Linked via shared directors
Fondation Francqui
via Chris Buyse · Director
→
Z.org KU Leuven
via Luc Debruyne · Bestuurder en lid van de algemene vergadering
→
BioSenic
via Chris Buyse · Director
former→
Catalent Gosselies
via Chris Buyse · Director
former→
Show 70 more companies with a shared director
CATALENT GOSSELIES HOLDING
via Chris Buyse · Director
former→
Celyad Oncology
via Chris Buyse · Director
former→
Fluvius System Operator
via Chris Buyse · Member of day-to-day management
former→
GlaxoSmithKline Biologicals
via Luc Debruyne · Director
former→
iTeos Belgium
via Chris Buyse · Director
former→
PIENTER-JAN
via Chris Buyse · Permanent representative
former→
SOFIA
via Chris Buyse · Permanent representative
former→
VLAAMSE ENERGIEHOLDING
via Chris Buyse · Director
former→
AEDIFICA
Shared director
→
Agfa-Gevaert
Shared director
→
Alumni Lovanienses
Shared director
→
ASSOCIATIE KU Leuven
Shared director
→
AXA BELGIUM
Shared director
→
BARCO
Shared director
→
BIO.BE
Shared director
→
COMMISSION CORPORATE GOVERNANCE
Shared director
→
Deloitte Legal-Lawyers
Shared director
→
ELIA ASSET
Shared director
→
Elia Group
Shared director
→
FINANCES ET INDUSTRIES
Shared director
→
FLUXYS
Shared director
→
FONDATION ULB
Shared director
→
FONDS FEDERAL DE LA RECHERCHE SCIENTIFIQUE
Shared director
→
Fonds voor wetenschappelijk Onderzoek - Vlaanderen
Shared director
→
Gimv
Shared director
→
ING BELGIQUE
Shared director
→
Katholieke Universiteit te Leuven
Shared director
→
Oxurion
Shared director
→
PATCOBEL
Shared director
→
Vlerick Business School
Shared director
→
VLERICK RESEARCH
Shared director
→
ALDEA GROUP
Shared corporate director
→
Aphea.Bio
Shared corporate director
→
ASCO INDUSTRIES
Shared corporate director
→
Aviapartner Belgium
Shared corporate director
→
Banqup Group
Shared corporate director
→
Belgian Mobile ID
Shared corporate director
→
BeLightning
Shared corporate director
→
BIOXODES
Shared corporate director
→
CALYOS
Shared corporate director
→
CI SAIL 2025
Shared corporate director
→
CISSOID
Shared corporate director
→
COMET TRAITEMENTS
Shared corporate director
→
COMET TYRE RECYCLING
Shared corporate director
→
COMETSAMBRE
Shared corporate director
→
ELECTRAWINDS
Shared corporate director
→
EPIMEDE
Shared corporate director
→
HEX - RAYS
Shared corporate director
→
Inbiose
Shared corporate director
→
LINEAS
Shared corporate director
→
LINEAS GROUP
Shared corporate director
→
OncoDNA
Shared corporate director
→
Orizio
Shared corporate director
→
Palais des Congrès
Shared corporate director
→
Publiwind
Shared corporate director
→
Sabena Aerospace Engineering
Shared corporate director
→
SmartSec
Shared corporate director
→
Smile Invest
Shared corporate director
→
Smile Invest Management Company
Shared corporate director
→
Société Anonyme Belge de Constructions Aéronautiques
Shared corporate director
→
Société Nationale de Construction Aérospatiale
Shared corporate director
→
SPARKI
Shared corporate director
→
THEODORUS IV
Shared corporate director
→
Triginta
Shared corporate director
→
Unibreda
Shared corporate director
→
VANBREDA RISK & BENEFITS
Shared corporate director
→
VIVES II - Louvain Technology Fund
Shared corporate director
→
ZEPHYR - FIN
Shared corporate director
→
Ownership & control
1 board mandateBoard mandates of this companythis company sits on their board1
2 locations
Group per the LEI register
4 funds4 funds in the register
Managed fund:American Beacon Cayman Trend Company, Ltd.
Managed fund:MassMutual Overseas Fund
Managed fund:NATIVE SAN & Company, L.L.C.
Managed fund:THE GOODHAVEN FUNDS TRUST
Capital and shareholders
Shareholders according to the acts
After 5 capital increases
act of 12-10-2017 ↗
- Désiré Collen Stichting (BE 0598.907.593) 25,042,100 EUR
- Pierre René Ghislain DRION 1,500 shares · 1,500,000 EUR
- Multifin (BE 0439.698.921) 9,480 shares · 9,675,300 EUR
- Federale Participatie- en Investeringsmaatschappij (BE 0253.445.063) 10,654 shares · 13,997,240 EUR
- Société Régionale d'Investissement de Wallonie (BE 0219.919.487) 7,500 shares · 7,500,000 EUR
- VF Capital (BE 0542.579.495) 11,040 shares · 11,252,400 EUR
- Katholieke Universiteit Leuven (BE 0419.052.173) 3,000 shares · 3,000,000 EUR
- Jonelinvest (BE 0432.136.087) 5,175 shares · 5,260,500 EUR
- Tolefi (BE 0449.147.711) 1,500 shares · 1,500,000 EUR
- Omnivale (BE 0807.508.766) 1,500 shares · 1,500,000 EUR
- Sambrinvest Spin-Off/Spin-Out (BE 0884.341.575) 1,500 shares · 1,500,000 EUR
- Spinventure (BE 0465.001.172) 720 shares · 763,200 EUR
- Société de Développement et de Participation du Bassin de Liège (BE 0426.624.509) 1,425 shares · 1,510,500 EUR
- EVDC Invest S.A. 1,425 shares · 1,510,500 EUR
- Marc Emmanuel NOLET DE BRAUWERE VAN STEENLAND 1,425 shares · 1,510,500 EUR
At incorporation
act of 20-05-2015 ↗
- Désiré Collen Stichting (BE 0598.907.593) founder
- Life Sciences Research Partners (BE 0435.768.243) founder
The Belgian State Gazette names shareholders only when an act mentions them; the share register itself is not published.
Capital over the years
- 22-01-2026 Capital increase of 4,499,000 EUR · to 105,737,717.50 EUR · 4,499 new shares · in cash
- 10-01-2018 Capital stated in the act · 101,238,717.50 EUR · 129,669 shares
- 12-10-2017 Capital reduction of 36,940,522.50 EUR · to 8,399,477.50 EUR · repaid to the shareholders
- 12-10-2017 Capital increase of 15,000,000 EUR · 15,000 new shares
- 12-10-2017 Capital increase of 8,268,000 EUR · 7,800 new shares
- 12-10-2017 Capital increase of 41,475,000 EUR · 41,475 new shares
- 12-10-2017 Capital increase of 14,007,900 EUR · 13,215 new shares
- 12-10-2017 Capital increase of 14,088,340 EUR · 6,839 new shares
Show 6 older capital entries
- 14-10-2016 Capital increase of 12,300,000 EUR · 12,300 new shares
- 14-10-2016 Capital increase of 7,715,000 EUR · 7,715 new shares
- 21-01-2016 Capital increase of 2,500,000 EUR · to 25,325,000 EUR · 2,500 new shares · in cash
- 14-08-2015 Capital increase of 4,325,000 EUR · to 22,825,000 EUR · 4,325 new shares · in cash
- 02-06-2015 Capital increase of 9,500,000 EUR · to 18,500,000 EUR · 9,500 new shares · in cash
- 20-05-2015 Incorporation · 9,000,000 EUR
Recognitions · licences · registrations
Legal Entity Identifier
967600DP3QW1O9VP6X78
Similar companies · same sector, comparable size
I4B - THE BELGIAN INFRASTRUCTURE FUND
BE 0721.470.261
Watermaal-Bosvoorde · Eq €133.9m
Maxus Fund
BE 0792.915.018
Nazareth · Eq €85.3m
UCB Ventures
BE 0667.816.096
Anderlecht · Eq €213.8m
EMV BEHEER
BE 0427.023.395
Oudsbergen · Eq €64.7m
QUAEROQ
BE 0862.330.988
Waregem · Eq €55.9m
Of 152 companies in sector 64310 we hold annual accounts for 73. 17 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPublic limited company
Founded07-05-2015
Fiscal year end31-12
Activities, NACEBEL 2025
64310Financial service activities, except insurance and pension funding
E-invoicing
Reachable via Peppol
Peppol ID
0208:0629896521
Registered
27-03-2026
Register as of 27 September 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.